Tessa Therapeutics names new director
12 April 2018 -

Tessa Therapeutics, an international clinical stage biopharmaceutical company focusing on cellular immunotherapy treatments for cancer, has named Goran Ando as its new independent director, it was reported yesterday.

Ando was the former Chairman of Novo Nordisk A/S.

Dr. Ando brings more than 35 years of international healthcare experience to Tessa Therapeutics. Starting his career at Pfizer, he held senior positions at global healthcare and pharmaceutical businesses including Bristol-Myers Squibb and GlaxoSmithKline, before joining Pharmacia AB as Executive VP and then as Deputy CEO in 1995. More recently, he served as the chief executive officer of Cell Tech Group PLC and has been a senior adviser to leading specialist healthcare investment group, Essex Woodlands, since 2007. Until March 2018, he had been a member of the of Novo Holdings A/S board of directors.